Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,706 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined Comprehensive Risk Score of the Estimation of Physiologic Ability and Surgical Stress and C-Reactive Protein-to-Albumin Ratio Is a Strong Prognostic Indicator of Long-term Outcomes in Colorectal Cancer.
Kato Y, Shigeta K, Tajima Y, Nakadai J, Seo Y, Kikuchi H, Seishima R, Okabayashi K, Kitagawa Y. Kato Y, et al. Among authors: kitagawa y. Dis Colon Rectum. 2024 Jun 20. doi: 10.1097/DCR.0000000000003348. Online ahead of print. Dis Colon Rectum. 2024. PMID: 38902835
Association between skin suture devices and incidence of incisional surgical site infection after gastrointestinal surgery: A systematic review and network meta-analysis.
Kouzu K, Kabata D, Shinkawa H, Shinji S, Ishinuki T, Tamura K, Uchino M, Ohge H, Shimizu J, Haji S, Mohri Y, Yamashita C, Kitagawa Y, Suzuki K, Kobayashi M, Kobayashi M, Hanai Y, Nobuhara H, Imaoka H, Yoshida M, Mizuguchi T, Mayumi T, Kitagawa Y. Kouzu K, et al. Among authors: kitagawa y. J Hosp Infect. 2024 Jun 18:S0195-6701(24)00205-6. doi: 10.1016/j.jhin.2024.04.029. Online ahead of print. J Hosp Infect. 2024. PMID: 38901769 Review.
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial.
Kato K, Machida R, Ito Y, Daiko H, Ozawa S, Ogata T, Hara H, Kojima T, Abe T, Bamba T, Watanabe M, Kawakubo H, Shibuya Y, Tsubosa Y, Takegawa N, Kajiwara T, Baba H, Ueno M, Takeuchi H, Nakamura K, Kitagawa Y; JCOG1109 investigators. Kato K, et al. Among authors: kitagawa y. Lancet. 2024 Jun 11:S0140-6736(24)00745-1. doi: 10.1016/S0140-6736(24)00745-1. Online ahead of print. Lancet. 2024. PMID: 38876133
Investigation of a new implant surface modification using phosphorylated pullulan.
Nagamoto K, Nakanishi K, Akasaka T, Abe S, Yoshihara K, Nakamura M, Hayashi H, Takemoto S, Tamura M, Kitagawa Y, Van Meerbeek B, Yoshida Y. Nagamoto K, et al. Among authors: kitagawa y. Front Bioeng Biotechnol. 2024 May 22;12:1378039. doi: 10.3389/fbioe.2024.1378039. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38840668 Free PMC article.
Prognostic significance of chronic kidney disease and impaired renal function in Japanese patients with COVID-19.
Tanaka H, Chubachi S, Asakura T, Namkoong H, Azekawa S, Otake S, Nakagawara K, Fukushima T, Lee H, Watase M, Sakurai K, Kusumoto T, Masaki K, Kamata H, Ishii M, Hasegawa N, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K. Tanaka H, et al. Among authors: kitagawa y. BMC Infect Dis. 2024 May 25;24(1):527. doi: 10.1186/s12879-024-09414-w. BMC Infect Dis. 2024. PMID: 38796423 Free PMC article.
2,706 results